A First Class stamp help with managerial accounting homework Mr Morris added that "the licensing process was competitive and Menarini was chosen for their extensive presence in their territories and their history of successful drug launches across Europe". The latter's vice chairman, Alberto Giovanni Aleotti, said that "the rapid onset of action and unique profile make Spedra an important treatment option for men with ED", adding that launches will occur in the major EU countries early next year.